![]() We performed a cohort study in a population of 714 patients with newly diagnosed T2D (patient demographics are shown in Table Table1), 1), using morbidity data from all patients with newly diagnosed T2D from the Continuous Morbidity Registration (CMR), a practice-based research network in the Nijmegen region located in the eastern part of the Netherlands. We limited neither the number nor the types of chronic comorbid diseases to be studied in advance. The aims of this study were to establish the prevalence and types of an extensive range of chronic comorbid diseases in patients with T2D at the time of their diabetes diagnosis, and to establish the incidence density of new chronic comorbid diseases in these patients over time. Consequently, it would be useful to assess the prevalence and the incidence of comorbid diseases in patients with T2D. ![]() The frequency and sequence in which comorbid diseases occur may have important implications for aetiology, prognosis, and management. To date, epidemiological research on comorbidity in T2D has been limited to prevalence estimates from cross-sectional studies only. Įpidemiologic descriptions of both concordant and discordant comorbidity in an unselected T2D population may increase understanding of the heterogeneity of populations with T2D, and may encourage consideration of co-existing discordant comorbid conditions in current T2D management. Recommendations for clinical approaches to comorbidity in general and of discordant combinations in particular are rarely provided in evidence-based (diabetes) guidelines. Diabetes patients with concordant and discordant comorbidity show similarly increased healthcare utilization. 'Discordant' combinations, that is, diseases without shared pathogenesis, risk factors, or management, remain largely unexplored. Previous studies focused mainly on 'concordant' comorbidity, that is, conditions that share pathogenesis, risk factors, and/or management plans with T2D (for instance, hypertension). The number of studies on comorbidity in T2D is limited. It also negatively influences their self-management and emotional well-being. Comorbidity has a negative effect on the quality of life of patients with diabetes, and substantially increases their healthcare utilization. Diabetes treatment may provide lower benefit to patients with diabetes and comorbidity. In primary care, over 40% of patients with diabetes also have comorbidity, which is as high as 70 to 95% in selected diabetes cohorts. When referring to a specific disease such as diabetes as an index condition, any co-occurring conditions are considered comorbidity. ![]() ![]() Diabetes mellitus (type 2 diabetes T2D) is a chronic disease with marked effects on mortality and healthcare expenditure, and its prevalence in the USA was estimated at 8% in 2010. The prevalence of multimorbidity is estimated at 16 to 58% in adults in primary care or population-based settings. With Linux and ZFS, QuTS hero supports advanced data reduction technologies for further driving down costs and increasing reliablility of SSD (all-flash) storage.Ageing of the population contributes to the increasing prevalence of diabetes and of multimorbidity, that is, the co-occurrence of multiple diseases within one person. QuTS hero is the operating system for high-end and enterprise QNAP NAS models. WIth Linux and ext4, QTS enables reliable storage for everyone with versatile value-added features and apps, such as snapshots, Plex media servers, and easy access of your personal cloud. QTS is the operating system for entry- and mid-level QNAP NAS.
0 Comments
Leave a Reply. |